(Q52212870)

27 April 2018

title

A research agenda for the study of therapeutic agents in adolescents. (English)

1 reference

27 April 2018

1 reference

1 reference

Rogers AS

1

1 reference

27 April 2018

publication date

1 December 1994

1 reference

27 April 2018

Journal of Adolescent Health

published in

1 reference

27 April 2018

volume

15

1 reference

27 April 2018

issue

8

1 reference

27 April 2018

page(s)

672-678

1 reference

27 April 2018

Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Drug glucuronidation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Developmental pharmacology in adolescence. The inauguration of a new field.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Effect of human growth hormone on amobarbital metabolism in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

The effect of age, gender, and sexual maturation on the caffeine breath test

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Pubertal changes in net renal tubular secretion of digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Ethnic differences in drug disposition and responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Guidelines for adolescent participation in research: current realities and possible resolutions.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Concentration- or effect-controlled clinical trials with sparse data

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Pharmacogenetic phenotyping and genotyping. Present status and future potential.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Postmarketing surveillance of the safety of cimetidine: 12 month mortality report

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

Cimetidine postmarket outpatient surveillance program. Interim report on phase I

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2894%2990635-1

7 January 2021

10.1016/S1054-139X(94)90635-1

Identifiers

DOI

1 reference

27 April 2018

1 reference

27 April 2018